Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers

NCT03515538 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

INDUSTRY

Sponsor class

Conditions

Oral Mucositis

Interventions

DRUG: RRx-001
DRUG: Cisplatin for injection
RADIATION: Radiation Therapy

Sponsor

EpicentRx, Inc.

Collaborators

[object Object]